Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,004
Award facts
- Contract value 100% obligated
- $17,004.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,004.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose, 2 pens per milliliter, with an ultimate completion date of January 13, 2026. This non-set-aside contract was awarded competitively on January 12, 2026, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This delivery order fulfills the Defense Logistics Agency's pharmaceutical procurement needs for military treatment facilities and veteran healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in the medical supply chain, with consistent delivery of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to defense and civilian federal agencies.
Quick answers
Who was awarded contract SPE2DR26F9DAQ?
SPE2DR26F9DAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9DAQ worth?
The government has obligated $17,004 on SPE2DR26F9DAQ.
Is contract SPE2DR26F9DAQ an order under another contract?
Yes. SPE2DR26F9DAQ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DAQ competed?
The extent of competition for SPE2DR26F9DAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award